# STX2

## Overview
STX2 is a gene that encodes the protein syntaxin 2, a member of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) family. Syntaxin 2 is a transmembrane protein that plays a pivotal role in mediating membrane fusion events essential for various cellular processes, including exocytosis, phagocytosis, and autophagy. The protein functions as an inhibitory SNARE, modulating the formation of SNARE complexes and thereby influencing the secretion of substances such as insulin and the clearance of phagocytic particles. STX2's involvement in these processes underscores its importance in maintaining cellular and organismal homeostasis. Dysregulation of STX2 expression or function has been implicated in several pathological conditions, including cancer metastasis, preeclampsia, and reproductive disorders, highlighting its clinical significance (Samanta2024Syntaxin2; Wang2018STX2; Dolai2018PancreatitisInduced).

## Function
Syntaxin 2 (STX2) is a SNARE protein that plays a critical role in various cellular processes, including exocytosis and phagocytosis. In pancreatic acinar cells, STX2 regulates exocytosis by influencing the formation of SNARE complexes. It acts as an inhibitory SNARE (i-SNARE), competing with other syntaxins like STX3 and STX4, thereby controlling the extent of exocytosis. This regulation is crucial for maintaining the balance of exocytosis in response to physiological stimuli, such as cholecystokinin (CCK) (Dolai2018PancreatitisInduced).

In macrophages, STX2 is involved in regulating phagocytosis by balancing the trafficking of non-lytic and lytic compartments. It inhibits excessive phagocytic uptake and facilitates the fusion of phagosomes with lysosomes, promoting the clearance of phagocytic particles. This function is vital for maintaining organismal homeostasis and defense against diseases (Samanta2024Syntaxin2).

In pancreatic β-cells, STX2 acts as an inhibitory SNARE, regulating insulin granule exocytosis. It competes with syntaxin-1A at granule docking sites, affecting insulin secretion. The flipping of STX2 across the plasma membrane relieves its inhibitory effect, promoting insulin secretion, which is essential for glucose homeostasis (Kang2022Plasma).

## Clinical Significance
Alterations in the expression of the STX2 gene have been implicated in several diseases. In colorectal cancer (CRC), STX2 is identified as an oncogene that promotes cancer invasion and metastasis. Its expression is upregulated in CRC tissues, particularly in metastatic cases, and is associated with poor prognosis and reduced overall survival. Mechanistically, STX2 interacts with tumor necrosis factor receptor-associated factor 6 (TRAF6) to activate the nuclear transcription factor-κB (NF-κB) signaling pathway, forming a positive feedback loop that enhances CRC metastasis (Wang2018STX2).

In preeclampsia, a pregnancy-related condition, STX2 expression is downregulated in placental tissues. This downregulation affects trophoblast cell proliferation, migration, and invasion, processes crucial for placental development. STX2 activates the PI3K-AKT signaling pathway, and its reduced expression may contribute to the pathophysiology of preeclampsia (Li2021STX2).

Mutations in STX2 have also been linked to non-obstructive azoospermia in humans. A specific homozygous frameshift mutation was identified in a patient, leading to spermatogenic failure characterized by maturation arrest and multinucleated spermatocytes, similar to observations in Stx2-deficient mice (Nakamura2018STX2is).

Additionally, genetic variations in STX2 are associated with von Willebrand factor (VWF) levels in type 1 von Willebrand disease (VWD) patients, influencing the bleeding phenotype (van2012Effect).

## Interactions
Syntaxin 2 (STX2) is involved in various protein interactions that regulate its function in cellular processes. In pancreatic acini, STX2 interacts with Atg16L1 and clathrin heavy chain (CHC-1), where it sequesters Atg16L1 from CHC-1, negatively regulating their assembly and thus autophagy. The deletion of STX2 enhances the assembly of Atg16L1 with CHC-1, promoting autophagosome formation (Dolai2018PancreatitisInduced). STX2 also forms non-fusogenic complexes with other SNARE proteins, such as STX3 and STX4, competing with them to regulate exocytosis and autophagy (Dolai2018PancreatitisInduced).

In human β-cells, STX2 colocalizes with syntaxin-1a at secretory granule docking sites, forming clusters that regulate insulin granule exocytosis. STX2 acts as an inhibitory SNARE by forming non-fusogenic complexes with priming factors Munc18 and Munc13, which are essential for the transition to a fusion-ready SNARE complex (Kang2022Plasma). STX2's ability to flip across the plasma membrane modulates its inhibitory action on insulin secretion by affecting SNARE complex formation (Kang2022Plasma).

In macrophages, STX2 is involved in regulating phagocytosis by interacting with early endosomes and VAMP4-positive compartments, influencing phagocytic uptake and phagolysosomal clearance (Samanta2024Syntaxin2).


## References


[1. (Kang2022Plasma) Fei Kang, Li Xie, Tairan Qin, Yifan Miao, Youhou Kang, Toshimasa Takahashi, Tao Liang, Huanli Xie, and Herbert Y. Gaisano. Plasma membrane flipping of syntaxin-2 regulates its inhibitory action on insulin granule exocytosis. Nature Communications, October 2022. URL: http://dx.doi.org/10.1038/s41467-022-33986-3, doi:10.1038/s41467-022-33986-3. This article has 5 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-33986-3)

2. (Samanta2024Syntaxin2) Syntaxin-2 inhibits excessive phagocytic uptake but promotes phagolysosomal clearance in macrophages. This article has 0 citations.

[3. (van2012Effect) Janine E. van Loon, Yvonne V. Sanders, Eva M. de Wee, Marieke J. H. A. Kruip, Moniek P. M. de Maat, and Frank W. G. Leebeek. Effect of genetic variation in stxbp5 and stx2 on von willebrand factor and bleeding phenotype in type 1 von willebrand disease patients. PLoS ONE, 7(7):e40624, July 2012. URL: http://dx.doi.org/10.1371/journal.pone.0040624, doi:10.1371/journal.pone.0040624. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0040624)

[4. (Wang2018STX2) Yongxia Wang, Honghai Xu, Hongli Jiao, Shuyang Wang, Zhiyuan Xiao, Yali Zhao, Jiaxin Bi, Wenting Wei, Shanshan Liu, Junfeng Qiu, Tingting Li, Li Liang, Yaping Ye, Wenting Liao, and Yanqing Ding. Stx2 promotes colorectal cancer metastasis through a positive feedback loop that activates the nf-κb pathway. Cell Death &amp; Disease, May 2018. URL: http://dx.doi.org/10.1038/s41419-018-0675-x, doi:10.1038/s41419-018-0675-x. This article has 15 citations.](https://doi.org/10.1038/s41419-018-0675-x)

[5. (Dolai2018PancreatitisInduced) Subhankar Dolai, Tao Liang, Abrahim I. Orabi, Douglas Holmyard, Li Xie, Dafna Greitzer-Antes, Youhou Kang, Huanli Xie, Tanveer A. Javed, Patrick P. Lam, Deborah C. Rubin, Peter Thorn, and Herbert Y. Gaisano. Pancreatitis-induced depletion of syntaxin 2 promotes autophagy and increases basolateral exocytosis. Gastroenterology, 154(6):1805-1821.e5, May 2018. URL: http://dx.doi.org/10.1053/j.gastro.2018.01.025, doi:10.1053/j.gastro.2018.01.025. This article has 46 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1053/j.gastro.2018.01.025)

[6. (Nakamura2018STX2is) Shigeru Nakamura, Yoshitomo Kobori, Yoshihiko Ueda, Yoko Tanaka, Hiromichi Ishikawa, Atsumi Yoshida, Momori Katsumi, Kazuki Saito, Akie Nakamura, Tsutomu Ogata, Hiroshi Okada, Hideo Nakai, Mami Miyado, and Maki Fukami. Stx2is a causative gene for nonobstructive azoospermia. Human Mutation, 39(6):830–833, April 2018. URL: http://dx.doi.org/10.1002/humu.23423, doi:10.1002/humu.23423. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23423)

[7. (Li2021STX2) Yan Li, Xian-li Sun, Chun-ling Ma, Chao Li, Ying Zhan, Wen-ting Li, Can Li, and Yi-hao Wang. Stx2 promotes trophoblast growth, migration, and invasion through activation of the pi3k-akt pathway in preeclampsia. Frontiers in Cell and Developmental Biology, July 2021. URL: http://dx.doi.org/10.3389/fcell.2021.615973, doi:10.3389/fcell.2021.615973. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.615973)